Serotonin Reuptake Inhibitors and Risk of Abnormal Bleeding

被引：39
|
作者：
Andrade, Chittaranjan [1 ]
Sharma, Eesha [2 ]
机构：
[1] Natl Inst Mental Hlth & Neurosci, Dept Psychopharmacol, Bangalore 560029, Karnataka, India
[2] King Georges Med Univ, Dept Psychiat, Lucknow 226003, Uttar Pradesh, India
来源：
PSYCHIATRIC CLINICS OF NORTH AMERICA | 2016年 / 39卷 / 03期
关键词：
Antidepressant; Serotonin reuptake inhibitor; Selective serotonin reuptake inhibitor; Bleeding; Postpartum hemorrhage; Intracranial hemorrhage; Nonsteroidal anti-inflammatory drugs; Antiplatelet drugs; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; POPULATION-BASED COHORT; POSTPARTUM HEMORRHAGE; PREADOLESCENT GIRL; ANTIDEPRESSANTS; METAANALYSIS; STROKE; SERTRALINE; THERAPY; SURGERY;
D O I：
10.1016/j.psc.2016.04.010
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
Serotonin reuptake inhibitors (SRIs) increase the risk of abnormal bleeding by lowering platelet serotonin and hence the efficiency of platelet-driven hemostasis; by increasing gastric acidity and possibly gastric ulceration; and by other mechanisms. The upper gastrointestinal tract is the commonest site of SRI-related abnormal bleeding; bleeding at this location may be increased by concurrent nonsteroidal anti-inflammatory drug therapy and by treatment with antiplatelet or anticoagulant drugs. Bleeding at this location may be reduced by concurrent administration of acid-suppressing drugs.
引用
收藏
页码：413 / +
页数：15
相关论文
共 50 条
  • [1] Selective serotonin reuptake inhibitors and abnormal bleeding: Is there an association?
    Chang, A
    Harper, GM
    Covinsky, KE
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2005, 20 : 262 - 262
  • [2] Selective Serotonin Reuptake Inhibitors and Risk of Cerebral Bleeding
    Hankey, Graeme J.
    STROKE, 2014, 45 (07) : 1917 - 1918
  • [3] Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants
    Meijer, WEE
    Heerdink, ER
    Nolen, WA
    Herings, RMC
    Leufkens, HGM
    Egberts, ACG
    ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (21) : 2367 - 2370
  • [4] Selective Serotonin Reuptake Inhibitors and Operative Bleeding Risk A Review of the Literature
    Roose, Steven P.
    Rutherford, Bret R.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2016, 36 (06) : 704 - 709
  • [5] Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins
    Schalekamp, Tom
    Klungel, Olaf H.
    Souverein, Patrick C.
    de Boer, Anthonius
    ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (02) : 180 - 185
  • [6] The use of serotonin reuptake inhibitors increases the risk of bleeding in patients with assist devices
    Bianca Auschra
    Markus J. Wilhelm
    Claudia Husung
    Josef Jenewein
    Andreas J. Flammer
    Lena Jellestad
    BMC Cardiovascular Disorders, 22
  • [7] The use of serotonin reuptake inhibitors increases the risk of bleeding in patients with assist devices
    Auschra, Bianca
    Wilhelm, Markus J.
    Husung, Claudia
    Jenewein, Josef
    Flammer, Andreas J.
    Jellestad, Lena
    BMC CARDIOVASCULAR DISORDERS, 2022, 22 (01)
  • [8] Selective serotonin reuptake inhibitors and increased bleeding risk: Are we missing something?
    Serebruany, VL
    AMERICAN JOURNAL OF MEDICINE, 2006, 119 (02): : 113 - 116
  • [9] Selective serotonin reuptake inhibitors and risk of upper GI bleeding: Confusion or confounding?
    Yuan, Yuhong
    Tsoi, Keith
    Hunt, Richard H.
    AMERICAN JOURNAL OF MEDICINE, 2006, 119 (09): : 719 - 727
  • [10] Autism Risk and Serotonin Reuptake Inhibitors
    Anderson, George M.
    JAMA PSYCHIATRY, 2019, 76 (05) : 547 - 548
12345